Back to Search
JULIE HODGE, M.D.
M.D.
MOHS-Micrographic Surgery Physician
NPI: 1629150396IndividualAccepts Medicare
Specialties, Licenses & Credentials
MOHS-Micrographic Surgery PhysicianPrimary
Dermatology — MOHS-Micrographic Surgery
Code: 207ND0101X
A48399(CA)
CMS Specialties
PrimaryDERMATOLOGY
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen.
PMID 19450631·Vaccine·2009
7-preclinical
Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges.
PMID 18777956·Oncology (Williston Park)·2008
6-review
Function of the Shaw potassium channel within the Drosophila circadian clock.
PMID 18509535·PLoS One·2008
7-preclinical
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
PMID 17613550·Hum Mol Genet·2007
6-review
Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.
PMID 14969388·J Bone Miner Res·2004
8-other
GM-CSF cannot substitute for M-CSF in human osteoclastogenesis.
PMID 15358207·Biochem Biophys Res Commun·2004
7-preclinical
Vaccine therapy of established tumors in the absence of autoimmunity.
PMID 12738742·Clin Cancer Res·2003
4-observational
Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion.
PMID 12649199·Cancer Res·2003
8-other
Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
PMID 14633725·Cancer Res·2003
7-preclinical
General keynote: vaccine strategies for the therapy of ovarian cancer.
PMID 12586096·Gynecol Oncol·2003
6-review
Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity.
PMID 12430632·Cancer Detect Prev·2002
6-review
Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules.
PMID 11348723·Vaccine·2001
4-observational
Costimulatory molecules in vaccine design.
PMID 10943315·Ernst Schering Res Found Workshop·2000
6-review
Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.
PMID 10922408·J Natl Cancer Inst·2000
7-preclinical
Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.
PMID 19603527·Genes Chromosomes Cancer·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1440 N HARBOR BLVD STE 300
FULLERTON, CA 92835 - Phone
- (714) 526-7546
Quick Facts
- NPI
- 1629150396
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile